Size: S / L

2013/9/13

Percutaneous cryoablation for stage IV lung cancer: A retrospective analysis

 

——Lizhi Niu, Jibing Chen, Fei Yao, Liang Zhou, Changming Zhang, Weifeng Wen, Xiangjun Bi,Yong Hu, Xianghao Piao, Feng Jiang, Jianying Zeng, Weiqun Liu, Jialiang Li, Lihua He,Feng Mu, Jiansheng Zuo, Kecheng Xu

Lung cancer is the most common cause of cancer-related death in adults [16]. In 2013, 228,190 new cases of lung cancer and 159,480 deaths from lung cancer are estimated in the United States [26]. The treatment of choice is surgical resection with lobectomy, but this is only suitable for localized, early-stage disease, with or without regional lymph node involvement [17,23]. Unfortunately, most patients have metastatic disease when diagnosis and are therefore not suitable for surgery [25]. Chemotherapy regimens are considered first line treatment for advanced and metastatic lung cancer [21]. However, these regimens are often associated with a decreased quality of life, without a significant improvement in prognosis.

 

。。。。。。